Conference call and webcast to be held at 4:30 PM ET

POMPANO BEACH, Fla., April 30,2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announces it will release its first quarter 2026 financial results on Thursday, May 14, 2026, and will host a conference call and webcast at 4:30 PM ET.

The webcast will feature an overview of the quarter from BioStem Technologies management. To register for the event, please click HERE.

Conference Call & Webcast Information:

• Conference ID: 9695874
• North America Toll-Free: (800) 715-9871
• International Toll: +1 (646) 307-1963
• Webcast Link: https://events.q4inc.com/attendee/844730655

About BioStem Technologies, Inc. (OTC: BSEM): BioStem Technologies is a publicly traded, biomedical innovator, focused on developing, manufacturing and commercializing advanced allograft solutions derived from perinatal tissue. The company leverages its industry-leading proprietary BioRetain®, CryoTek® and SteriTek® processing technologies, designed to optimize the preservation of the natural properties of these tissues, supporting their use in clinical settings. Its allografts are used by clinicians across a wide range of specialties. With a growing portfolio of products, expanding clinical research initiatives, and a national commercial footprint, BioStem is committed to advancing innovation in regenerative medicine.

BioStem Technologies’ quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks (“AATB”). These systems and procedures are established in compliance with current Good Tissue Practices (“cGTP”) and current Good Manufacturing Processes (“cGMP”). BioStem’s portfolio of quality brands includes its Neox®, Clarix®, VENDAJE® and American Amnion™ product lines.

Join BioStem’s Distribution List & Social Media:
To follow the latest developments at BioStem, sign up for the Company’s email distribution list HERE, and follow us on X and LinkedIn.

Contact BioStem:
Website: www.biostemtechnologies.com
E-Mail: pr@biostemtech.com
X: @BSEM_Tech
Facebook: BioStemTechnologies
Phone: 954-380-8342

Investor Relations:
Philip Trip Taylor, Gilmartin
Group E-Mail: ir@biostemtech.com

Public Relations:
Jennifer Horton, Relevance
jennifer@relevance.com

Source: BioStem Technologies, Inc.

The latest news and updates relating to $BSEM are available in the company’s newsroom at: https://tinyurl.com/bsemnewsroom

$BSEM BioStem Technologies will release Q1 2026 results May 14, followed by a webcast at 4:30 PM ET covering performance and growth updates https://t.co/iBf0w3wi8P The latest news and updates relating to $BSEM are available in the company’s newsroom at: https://t.co/TSHiKG9ZI3 pic.twitter.com/tBJ9lC82v9

The post BioStem Technologies to Host First Quarter 2026 Financial Results Conference Call on May 14, 2026 first appeared on Prism Media Wire.

This contant was orignally distributed by PRISM Mediawire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is BioStem Technologies to Host First Quarter 2026 Financial Results Conference Call on May 14, 2026.